Cite

    Philippe A. Cassier et al.. “Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour.” European journal of cancer, vol. 141, 2020, pp. 162–170. http://access.bl.uk/ark:/81055/vdc_100120046162.0x00002b